CompletedNCT00453609
Long-acting naltrexone for alcohol dependence in serious mental illness
About this title
Read the official source — NCT00453609Medication studyAges 18–69United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 69 years.
- Listed locations
- Syracuse and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- State University of New York - Upstate Medical University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 69 Years
- Official registry ID
- NCT00453609
- Official title
Show the full official title
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI): An Open Prospective Pilot Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Syracuse
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is State University of New York - Upstate Medical University, a university.
Did this study involve medication?
Yes. The study involved medication, including long-lasting injectable naltrexone.
Who was this study for?
Listed age limits: 18 years to 69 years.
